Alwin Krämer
Impact in
- Cell Biology top 0.5%
- Microtubule and mitosis dynamics
- Oncology top 1%
- Cancer-related Molecular Pathways
Papers in
-
- DNA Repair Mechanisms 16
- Hematology 51
- Acute Myeloid Leukemia Research 43
- Chronic Myeloid Leukemia Treatments 15
- Co-authors
- Jiří Bártek (9 shared papers)Claudia Lukas (2 shared papers)Torben F. Ørntoft (1 shared paper)Zuzana Hořejšı́ (1 shared paper)Jiřina Bártková (1 shared paper)Karen Koed (1 shared paper)Per Guldberg (1 shared paper)Maxwell Sehested (1 shared paper)
- Journals
- Blood (19 papers)International Journal of Cancer (6 papers)Cell Cycle (6 papers)Cancer Research (5 papers)Journal of Clinical Oncology (4 papers)
- Partner nations
- GermanyUnited StatesDenmark
In The Last Decade
Alwin Krämer
125 papers receiving 6.1k citations
Alwin Krämer's Hit Papers
Peers
Comparison fields: 5 of 128
- Cell Biology 1.8k
- Oncology 2.1k
- Hematology 810
- Molecular Biology 3.9k
- Cancer Research 757
Countries citing papers authored by Alwin Krämer
This map shows the geographic impact of Alwin Krämer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alwin Krämer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alwin Krämer more than expected).
Fields of papers citing papers by Alwin Krämer
This network shows the impact of papers produced by Alwin Krämer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alwin Krämer. The network helps show where Alwin Krämer may publish in the future.
Co-authors
The 25 scholars most cited alongside Alwin Krämer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 132 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis Hit paper breakdown → | 2005 | 2231 |
| 2 | 2004 | 270 | |
| 3 | 2014 | 191 | |
| 4 | 2007 | 153 | |
| 5 | 2010 | 149 | |
| 6 | 2012 | 148 | |
| 7 | 2014 | 129 | |
| 8 | 2011 | 93 | |
| 9 | 2006 | 90 | |
| 10 | 2009 | 74 | |
| 11 | 2011 | 71 | |
| 12 | 2011 | 69 | |
| 13 | 2004 | 68 | |
| 14 | 2020 | 65 | |
| 15 | 2002 | 63 | |
| 16 | 2009 | 62 | |
| 17 | 2012 | 62 | |
| 18 | 2005 | 61 | |
| 19 | 2007 | 60 | |
| 20 | 2013 | 58 |
About Alwin Krämer
Alwin Krämer is a scholar working on Molecular Biology, Hematology, Oncology, Cell Biology and Genetics, having authored 132 papers that have together received 6.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (43 papers), Microtubule and mitosis dynamics (40 papers), Cancer Diagnosis and Treatment (27 papers), DNA Repair Mechanisms (16 papers), Chronic Myeloid Leukemia Treatments (15 papers), Cancer-related Molecular Pathways (15 papers), Cancer Genomics and Diagnostics (11 papers) and Chronic Lymphocytic Leukemia Research (11 papers). The work is most often cited by research in Cell Biology (1.8k citations), Oncology (2.1k citations), Hematology (810 citations), Molecular Biology (3.9k citations) and Cancer Research (757 citations). Alwin Krämer has collaborated with scholars based in Germany, United States and Denmark. Frequent co-authors include Jiří Bártek, Claudia Lukas, Torben F. Ørntoft, Zuzana Hořejšı́, Jiřina Bártková, Karen Koed, Per Guldberg, Maxwell Sehested, Jahn M. Nesland and Frederic Tort. Their work appears in journals such as Blood, International Journal of Cancer, Cell Cycle, Cancer Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.